Table 1.
Clinicopathological characteristics of CRC patients included into a study.
| TNM stage | I-II | III-IV |
|---|---|---|
| N | 5 | 13 |
| Gender | F 1 | F 8 |
| M 4 | M 5 | |
| Age (years) | 74 | 75 |
| Mean [min-max] | [67–80] | [63–88] |
| CD133+ [%] | 9 | 68* |
| Mean [min-max] | [2–20] | [34–96] |
| FasL+ [%] | 56 | 78* |
| Mean [min-max] | [53–59] | [54–96] |
| Proliferation rate1 | 1 | 1.2* |
| Mean [min-max] | [0.6–1.4] | [0.6–2.9] |
F-females, M-men. *significantly different from the TNM I-II group, p < 0.05, U Mann-Whitney test; 1fold increase of the number of CD133+ cells measured during passage.